Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 21

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 21
---
3 Company Warrants prior to the Closing. |

10

QUESTIONS AND ANSWERS The following are some questions that you, as a TuHURA or Kineta stockholder, may have regarding the Mergers and the other matters being considered at the TuHURA and Kineta special meetings, and brief answers to those questions. You are urged to carefully read this joint proxy statement/prospectus and the other documents referred to in this joint proxy statement/prospectus in their entirety because this section may not provide all the information that is important to you regarding these matters. Additional important information is contained in the annexes to this joint proxy statement/prospectus.

| Q: | Why am I receiving this joint proxy statement/prospectus? |

| A: | You are receiving this joint proxy statement/prospectus because TuHURA has agreed to acquire Kineta through a                                                                                                                                     
 series of mergers whereby Kineta will continue as the Surviving Company and a wholly-owned privately held subsidiary of TuHURA. The Merger Agreement governs the terms of the Mergers and is attached to this joint proxy statement/prospectus as 
 Annex A.                                                                                                                                                                                                                                          |

| In order to complete the Mergers, among other things, TuHURA stockholders must approve the Authorized Share                                                                                                                                             
 Increase Proposal and Kineta stockholders must approve the Merger Agreement Proposal. TuHURA and Kineta are holding special meetings of their respective stockholders to obtain, among other things, approval of the Authorized Share Increase Proposal 
 and the Merger Agreement Proposal, respectively.                                                                                                                                                                                                        |

| TuHURA stockholders will also be asked to approve the Delaware Conversion Proposal and the TuHURA Adjournment                                                                                                                                         
 Proposal. TuHURA stockholders will also be asked to approve the director nominees set forth in the Delaware Election Proposal, the Executive Compensation Proposal and the Auditor Ratification Proposal, which are being solicited from the TuHURA   
 stockholders in connection with the TuHURA special meeting in lieu of annual meeting. This document serves as the annual report of TuHURA provided in connection with the special meeting in lieu of annual meeting. Kineta stockholders will also be 
 asked to approve, on an advisory (non-binding) basis, the Compensation Proposal and to approve the Kineta Adjournment Proposal.                                                                                                                       |

Your vote is very important, regardless of the number of shares that you own. The approval of the Authorized Share Increase Proposal and the Merger Agreement Proposal are conditions to the obligations of TuHURA and Kin